Sign in or create a free account to view this dataset's chart and data table.
Key Takeaway
- Sales grew at a CAGR of 7% between FY 2019–20 and FY 2024–25, indicating a positive growth trajectory. The category includes products for bloat, diarrhoea, scours and other digestive conditions, alongside laxatives and antispasmodics. The growth rate indicates an expanding sales trend over the five-year period.
About This Dataset
Annual sales data for animal health alimentary system medicines used to treat bloat, diarrhoea and scours, as well as laxatives, purgatives, lubricants and antispasmodics. The dataset provides aggregated sales values by financial year, with each financial year running from 1 July to 30 June.
Methodology
Sign in or create a free account to view this dataset's methodology and sources.
Available formats: Excel, CSV, PNG, PDF.
Transform Data Into Better Business Decisions
Join organizations that rely on statSCALAR for trusted market intelligence, industry statistics, commodity insights and enterprise research.